A new biomarker of cardiac resynchronization therapy response: cGMP to mature BNP ratio
CONCLUSIONS: The cGMP to emBNP ratio could be utilized as a predictive biomarker of CRT responders. (Clinical Study on Responder Prediction in Cardiac Resynchronization Therapy Using Individual Molecular Measurement of Natriuretic Peptide: UMIN R000038927).PMID:35016810 | DOI:10.1016/j.jjcc.2021.12.015
Source: Journal of Cardiology - Category: Cardiology Authors: Yasuhiro Yokoyama Naoya Kataoka Michikazu Nakai Ayaka Matsuo Akihiro Fujiwara Akinori Wakamiya Nobuhiko Ueda Kenzaburo Nakajima Tsukasa Kamakura Mitsuru Wada Kenichiro Yamagata Kohei Ishibashi Yuko Inoue Koji Miyamoto Satoshi Nagase Takashi Noda Takeshi A Source Type: research
More News: Brain | Cardiac Resynchronization Therapy | Cardiology | Heart | Heart Failure | Neurology | Study